Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 38403 | 15.29 |
09:34 ET | 30976 | 15.39 |
09:36 ET | 17860 | 15.295 |
09:38 ET | 22854 | 15.3 |
09:39 ET | 28221 | 15.2 |
09:41 ET | 17256 | 15.35 |
09:43 ET | 16121 | 15.3998 |
09:45 ET | 5977 | 15.38 |
09:48 ET | 9601 | 15.28 |
09:50 ET | 5837 | 15.27 |
09:52 ET | 1081 | 15.31 |
09:54 ET | 8616 | 15.34 |
09:56 ET | 3123 | 15.345 |
09:57 ET | 3250 | 15.375 |
09:59 ET | 1852 | 15.39 |
10:01 ET | 19272 | 15.425 |
10:03 ET | 4966 | 15.45 |
10:06 ET | 6329 | 15.36 |
10:08 ET | 14700 | 15.31 |
10:10 ET | 3124 | 15.31 |
10:12 ET | 27330 | 15.31 |
10:14 ET | 17390 | 15.28 |
10:15 ET | 7153 | 15.33 |
10:17 ET | 11868 | 15.36 |
10:19 ET | 28016 | 15.395 |
10:21 ET | 20305 | 15.46 |
10:24 ET | 20040 | 15.51 |
10:26 ET | 13522 | 15.49 |
10:28 ET | 2011 | 15.515 |
10:30 ET | 2649 | 15.46 |
10:32 ET | 3576 | 15.45 |
10:33 ET | 1363 | 15.48 |
10:35 ET | 1500 | 15.51 |
10:37 ET | 63960 | 15.61 |
10:39 ET | 10764 | 15.56 |
10:42 ET | 884 | 15.54 |
10:44 ET | 3485 | 15.535 |
10:46 ET | 3246 | 15.55 |
10:48 ET | 600 | 15.55 |
10:50 ET | 16065 | 15.57 |
10:51 ET | 2914 | 15.54 |
10:53 ET | 5518 | 15.515 |
10:55 ET | 1847 | 15.52 |
10:57 ET | 2300 | 15.515 |
11:00 ET | 5426 | 15.5 |
11:02 ET | 12455 | 15.47 |
11:04 ET | 11330 | 15.45 |
11:06 ET | 8700 | 15.425 |
11:08 ET | 2471 | 15.42 |
11:09 ET | 800 | 15.44 |
11:11 ET | 4787 | 15.395 |
11:13 ET | 9082 | 15.375 |
11:15 ET | 10947 | 15.3801 |
11:18 ET | 2300 | 15.41 |
11:20 ET | 3388 | 15.4 |
11:22 ET | 1850 | 15.425 |
11:24 ET | 700 | 15.45 |
11:26 ET | 2545 | 15.43 |
11:27 ET | 6274 | 15.46 |
11:29 ET | 1900 | 15.46 |
11:31 ET | 7442 | 15.45 |
11:33 ET | 1275 | 15.47 |
11:36 ET | 400 | 15.47 |
11:38 ET | 2991 | 15.4424 |
11:40 ET | 20923 | 15.48 |
11:42 ET | 15000 | 15.44 |
11:44 ET | 5128 | 15.43 |
11:45 ET | 1918 | 15.43 |
11:47 ET | 13741 | 15.435 |
11:49 ET | 6369 | 15.37 |
11:51 ET | 8310 | 15.395 |
11:54 ET | 4449 | 15.41 |
11:56 ET | 1525 | 15.4191 |
11:58 ET | 4556 | 15.44 |
12:00 ET | 3241 | 15.42 |
12:02 ET | 593 | 15.4 |
12:03 ET | 950 | 15.43 |
12:05 ET | 1011 | 15.38 |
12:07 ET | 5606 | 15.37 |
12:09 ET | 8761 | 15.36 |
12:12 ET | 3235 | 15.26 |
12:14 ET | 41362 | 15.255 |
12:16 ET | 3175 | 15.233 |
12:18 ET | 6490 | 15.225 |
12:20 ET | 8068 | 15.27 |
12:21 ET | 2872 | 15.31 |
12:23 ET | 5447 | 15.32 |
12:25 ET | 8228 | 15.31 |
12:27 ET | 11328 | 15.27 |
12:30 ET | 18010 | 15.22 |
12:32 ET | 19909 | 15.22 |
12:34 ET | 790 | 15.21 |
12:36 ET | 12524 | 15.18 |
12:38 ET | 2560 | 15.17 |
12:39 ET | 8768 | 15.1975 |
12:41 ET | 1851 | 15.2 |
12:43 ET | 2658 | 15.19 |
12:45 ET | 3242 | 15.25 |
12:48 ET | 13339 | 15.24 |
12:50 ET | 6842 | 15.215 |
12:52 ET | 1550 | 15.22 |
12:54 ET | 2501 | 15.21 |
12:56 ET | 5501 | 15.215 |
12:57 ET | 1048 | 15.21 |
12:59 ET | 8027 | 15.23 |
01:01 ET | 1204 | 15.225 |
01:03 ET | 1000 | 15.23 |
01:06 ET | 2054 | 15.24 |
01:08 ET | 1520 | 15.24 |
01:10 ET | 1112 | 15.24 |
01:12 ET | 7380 | 15.25 |
01:14 ET | 3980 | 15.21 |
01:15 ET | 6500 | 15.22 |
01:17 ET | 650 | 15.22 |
01:19 ET | 256 | 15.22 |
01:21 ET | 987 | 15.2 |
01:24 ET | 1500 | 15.21 |
01:26 ET | 13168 | 15.19 |
01:28 ET | 4814 | 15.205 |
01:30 ET | 3589 | 15.16 |
01:32 ET | 13006 | 15.21 |
01:33 ET | 1500 | 15.205 |
01:35 ET | 11600 | 15.225 |
01:37 ET | 1009 | 15.24 |
01:39 ET | 6000 | 15.22 |
01:42 ET | 12597 | 15.24 |
01:44 ET | 3223 | 15.25 |
01:46 ET | 394 | 15.26 |
01:48 ET | 6000 | 15.3 |
01:50 ET | 6526 | 15.29 |
01:51 ET | 3445 | 15.31 |
01:53 ET | 1135 | 15.3063 |
01:55 ET | 5265 | 15.325 |
01:57 ET | 7917 | 15.32 |
02:00 ET | 25049 | 15.325 |
02:02 ET | 6630 | 15.34 |
02:04 ET | 1385 | 15.31 |
02:06 ET | 2331 | 15.3 |
02:08 ET | 1244 | 15.31 |
02:09 ET | 4186 | 15.33 |
02:11 ET | 9901 | 15.26 |
02:13 ET | 15949 | 15.2801 |
02:15 ET | 4625 | 15.29 |
02:18 ET | 5793 | 15.29 |
02:20 ET | 500 | 15.3 |
02:22 ET | 9220 | 15.2699 |
02:24 ET | 500 | 15.26 |
02:26 ET | 1965 | 15.26 |
02:27 ET | 5009 | 15.27 |
02:29 ET | 860 | 15.268 |
02:31 ET | 1100 | 15.29 |
02:33 ET | 1181 | 15.3 |
02:36 ET | 3144 | 15.33 |
02:38 ET | 300 | 15.345 |
02:40 ET | 10810 | 15.3641 |
02:42 ET | 12546 | 15.42 |
02:44 ET | 3077 | 15.47 |
02:45 ET | 5826 | 15.55 |
02:47 ET | 11194 | 15.544 |
02:49 ET | 20406 | 15.56 |
02:51 ET | 7314 | 15.57 |
02:54 ET | 21373 | 15.525 |
02:56 ET | 23450 | 15.66 |
02:58 ET | 11722 | 15.65 |
03:00 ET | 17067 | 15.69 |
03:02 ET | 25027 | 15.705 |
03:03 ET | 2708 | 15.7 |
03:05 ET | 3811 | 15.73 |
03:07 ET | 7566 | 15.64 |
03:09 ET | 18557 | 15.64 |
03:12 ET | 3905 | 15.67 |
03:14 ET | 1426 | 15.7 |
03:16 ET | 2981 | 15.71 |
03:18 ET | 3331 | 15.7 |
03:20 ET | 5735 | 15.705 |
03:21 ET | 1200 | 15.72 |
03:23 ET | 1600 | 15.7131 |
03:25 ET | 3246 | 15.74 |
03:27 ET | 11731 | 15.81 |
03:30 ET | 10834 | 15.815 |
03:32 ET | 5641 | 15.78 |
03:34 ET | 6382 | 15.77 |
03:36 ET | 5141 | 15.76 |
03:38 ET | 5825 | 15.7901 |
03:39 ET | 6982 | 15.835 |
03:41 ET | 6847 | 15.87 |
03:43 ET | 12978 | 15.8 |
03:45 ET | 7185 | 15.825 |
03:48 ET | 2035 | 15.85 |
03:50 ET | 19949 | 15.8599 |
03:52 ET | 15607 | 15.835 |
03:54 ET | 20078 | 15.875 |
03:56 ET | 52112 | 15.85 |
03:57 ET | 15651 | 15.87 |
03:59 ET | 70253 | 15.9 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 2.4B | 72.1x | --- |
ADMA Biologics Inc | 2.4B | -513.7x | --- |
Vericel Corp | 2.2B | 4,553.3x | --- |
Twist Bioscience Corp | 2.9B | -14.9x | --- |
Arrowhead Pharmaceuticals Inc | 3.0B | -5.8x | --- |
Maravai LifeSciences Holdings Inc | 2.2B | -8.5x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.23 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 72.1x |
Price/Sales (TTM) | 8.5 |
Price/Cash Flow (TTM) | 59.2x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.